YUHSpace: Dept. of Internal Medicine (내과학교실)

YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)Dept. of Internal Medicine (내과학교실)

Dept. of Internal Medicine (내과학교실)

Researcher List

Keyword Cloud

Journal Categories

Highly Cited Articles

Trastuzumab in combination with chemotherapy versus chemotherapy alone f...

Yung-Jue Bang ; Eric Van Cutsem ; Andrea Feyereislova ; Hyun C Chung ; Lin Sh... LANCET, Vol.376(9742) : 687-697, 2010

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

Jean-Charles Soria ; Yuichiro Ohe ; Johan Vansteenkiste ; Thanyanan Reungwetw... NEW ENGLAND JOURNAL OF MEDICINE, Vol.378(2) : 113-125, 2018

Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer

S.J. Antonia ; A. Villegas ; D. Daniel ; D. Vicente ; S. Murakami ; R. Hui ; ... NEW ENGLAND JOURNAL OF MEDICINE, Vol.377(20) : 1919-1929, 2017

This table browses all dspace content
Issue Date	Title	Journal Title
2025	Genotype-based prognosis prediction for MEN1-Related pancreatic neuroendocrine tumors in Korean patients a single-center retrospective study	PANCREATOLOGY
2025	INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer	JOURNAL OF CLINICAL ONCOLOGY
2025	Association Between Plasma Granzyme B Levels, Organ Failure, and 28-Day Mortality Prediction in Patients with Sepsis	JOURNAL OF CLINICAL MEDICINE
2025	Associations of Healthcare Utilization and Health Expenditures in Older Adults With Osteoarthritis: Korean Health Panel Survey Study	INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES
2025	KASL clinical practice guidelines for the management of metabolic dysfunction-associated steatotic liver disease 2025	CLINICAL AND MOLECULAR HEPATOLOGY
2025	A phase III trial of adjuvant ribociclib plus endocrine therapy versus endocrine therapy alone in patients with HR-positive/HER2-negative early breast cancer: final invasive disease-free survival results from the NATALEE trial	ANNALS OF ONCOLOGY
2025	Outcomes after medical treatment for primary aldosteronism: an international consensus and analysis of treatment response in an international cohort	LANCET DIABETES & ENDOCRINOLOGY
2025	Reply to the Letter to the Editor regarding 'PFS, OS or toxicity: what is the most important factor in the treatment of EGFR-mutated lung cancer?' by T. Nishimura and H. Fujimoto	ANNALS OF ONCOLOGY
2025	Pathologic complete response following salvage surgery after lazertinib treatment in advanced EGFR-mutated lung adenocarcinoma: case report and literature review	TRANSLATIONAL LUNG CANCER RESEARCH
2025	Assessing the clinical impact of cardiac intensivists in cardiac intensivecare units: results from the RESCUE registry	BMC CARDIOVASCULAR DISORDERS
2025	Amivantamab plus Lazertinib in Previously Untreated EGFR-Mutated Advanced NSCLC Reply	NEW ENGLAND JOURNAL OF MEDICINE
2025	Diffuse Interstitial Fibrosis of the Myocardium Predicts Outcome in Moderate and Asymptomatic Severe Aortic Stenosis	JACC-CARDIOVASCULAR IMAGING
2025	Angiotensin receptor-neprilysin inhibitor adherence and outcomes in heart failure with reduced ejection fraction	ESC HEART FAILURE
2025	Continuous multimodal data supply chain and expandable clinical decision support for oncology	NPJ DIGITAL MEDICINE(Nature partner journals digital medicine Digital medicine)
2025	Romosozumab following denosumab improves lumbar spine bone mineral density and trabecular bone score greater than denosumab continuation in postmenopausal women	JOURNAL OF BONE AND MINERAL RESEARCH
2025	Twenty-Year Trends in Osteoporosis Treatment and Post-Fracture Care in South Korea: A Nationwide Study	Journal of Bone Metabolism
2025	The Korean Organ Transplant Registry (KOTRY): Third Official Adult Heart Transplant Report	KOREAN CIRCULATION JOURNAL
2025	Association of clonal hematopoiesis of indeterminate potential with myocardial characteristic differences in non-ischemic heart failure	Heliyon
2025	이차성 이상지질혈증에 대한 한국지질동맥경화학회 2024년 합의안	대한내과학회지
2025	일개 국내 의과대학 교육프로그램 질 향상을 위한 평가체계 틀 개발에 관한 연구	Korean Medical Education Review(의학교육논단)